| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| AADXApplied Aerospace & Defense, Inc. | $2.6B | — | $498.76M | +24.8% | -$17.02M | $18.11M | $400.49M | AI pending |
| AAPAdvance Auto Parts Inc | $2.6B | 31.3× | $8.6B | -5.4% | $44M | $3.12B | $3.39B | AI pending |
| HURNHuron Consulting Group Inc. | $2.6B | 24.5× | $1.66B | +11.9% | $105.04M | $26.46M | $854.74M | AI pending |
| BFLYButterfly Network, Inc. | $2.59B | — | $97.61M | +19.0% | -$77.06M | $124.66M | — | AI pending |
| VISNVistance Networks, Inc. | $2.59B | 12.2× | $1.93B | +39.7% | $2.28B | $113.6M | $0 | AI pending |
| SSMRSunshine Silver Mining & Refining Co | $2.59B | — | $501.29K | +421.8% | — | $288.72M | — | AI pending |
| NEOGNeogen Corp | $2.58B | — | $870.4M | -2.7% | -$7.9M | $185.5M | $1.59B | AI pending |
| WGSGeneDx Holdings Corp. | $2.58B | — | $427.54M | +40.0% | -$21.02M | $60.32M | $96.84M | AI pending |
| NWLNewell Brands Inc. | $2.58B | — | $7.2B | -5.0% | -$285M | $209M | $5.01B | AI pending |
| COHUCohu Inc | $2.58B | — | $452.96M | +12.7% | -$74.27M | $219.61M | $296.23M | AI pending |
| STUBStubHub Holdings, Inc. | $2.57B | — | $1.75B | -1.4% | -$1.91B | $1.69B | $1.4B | AI pending |
| TDCTeradata Corp | $2.57B | 5.8× | $1.66B | -5.0% | $130M | $414M | $0 | AI pending |
| GSHDGoosehead Insurance, Inc. | $2.57B | 52.8× | $365.3M | — | $27.83M | $23.66M | $317.37M | AI pending |
| CSANCosan S.A. | $2.56B | — | R$43.95B | +11.4% | -R$9.42B | R$16.9B | R$66.46B | AI pending |
| IVTInvenTrust Properties Corp. | $2.56B | 169.1× | $299.17M | +9.2% | $111.42M | $74.9M | $1.09B | AI pending |
| RAREUltragenyx Pharmaceutical Inc. | $2.56B | — | $673M | +20.2% | -$575M | $125M | — | AI pending |
| MHMcGraw Hill, Inc. | $2.56B | 27.6× | $2.1B | +0.1% | $35.32M | $193.64M | $2.57B | AI pending |
| PGENPrecigen, Inc. | $2.56B | — | $9.68M | +146.7% | -$250.64M | $16.33M | $93.88M | AI pending |
| ACHCAcadia Healthcare Company, Inc. | $2.56B | — | $3.31B | +5.0% | -$1.1B | $158.47M | $2.53B | AI pending |
| TRVITrevi Therapeutics, Inc. | $2.56B | — | — | — | — | $54.3M | — | AI pending |